TCR2 Therapeutics Inc.
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

Last updated:

Abstract:

Provided herein are T cell receptor (TCR) fusion proteins (TFPs), T cells engineered to express one or more TFPs, and methods of use thereof for the treatment of diseases, including cancer.

Status:
Application
Type:

Utility

Filling date:

13 Jun 2018

Issue date:

18 Mar 2021